These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1807179)

  • 1. [Drug-induced rhabdomyolysis].
    Chichmanian RM; Mignot G; Spreux A
    Ann Med Interne (Paris); 1991; 142(8):587-91. PubMed ID: 1807179
    [No Abstract]   [Full Text] [Related]  

  • 2. Rhabdomyolysis after concomitant use of cyclosporine and simvastatin in a patient transplanted for multiple myeloma.
    Tong J; Laport G; Lowsky R
    Bone Marrow Transplant; 2005 Oct; 36(8):739-40. PubMed ID: 16086041
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
    Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
    Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute rhabdomyolysis during treatment with epsilon aminocaproic acid. Description of two cases.
    Luliri P; Bobbio-Pallavicini E; Gorini M
    Haematologica; 1983; 68(5):664-9. PubMed ID: 6416944
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rhabdomyolysis caused by antilipemic agents in a patient with terminal nephropathy undergoing continuous ambulatory peritoneal dialysis (CAPD)].
    Santa Cruz PL; Barile M; Sánchez O; Agüero F
    Nefrologia; 2002; 22(1):87-8. PubMed ID: 11987693
    [No Abstract]   [Full Text] [Related]  

  • 6. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.
    Chang JT; Staffa JA; Parks M; Green L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhabdomyolysis and acute renal failure following a switchover of therapy between two fibric acid derivatives.
    Kamaliah MD; Sanjay LD
    Singapore Med J; 2001 Aug; 42(8):368-72. PubMed ID: 11764054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute renal failure secondary to fenofibrate monotherapy-induced rhabdomyolysis.
    Tahmaz M; Kumbasar B; Ergen K; Ure U; Karatemiz G; Kazancioglu R
    Ren Fail; 2007; 29(7):927-30. PubMed ID: 17994463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin-induced rhabdomyolysis in a CsA-treated renal transplant recipient.
    Gumprecht J; Zychma M; Grzeszczak W; Kuźniewicz R; Burak W; Zywiec J; Karasek D; Otulski I; Mosur M
    Med Sci Monit; 2003 Sep; 9(9):CS89-91. PubMed ID: 12960932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhabdomyolysis caused by Commiphora mukul, a natural lipid-lowering agent.
    Bianchi A; Cantù P; Firenzuoli F; Mazzanti G; Menniti-Ippolito F; Raschetti R
    Ann Pharmacother; 2004; 38(7-8):1222-5. PubMed ID: 15187214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rhabdomyolysis under treatment by ciprofibrate in the nephrotic syndrome].
    Baglin A; Lasserre N; Prinseau J; Lebas M
    Therapie; 1987; 42(2):247-8. PubMed ID: 3617003
    [No Abstract]   [Full Text] [Related]  

  • 12. Rhabdomyolysis associated with cerivastatin plus gemfibrozil combined regimen.
    Marsà Carretero M; Alos Manrique C; Valles Callol JA
    Br J Gen Pract; 2002 Mar; 52(476):235-6. PubMed ID: 12030671
    [No Abstract]   [Full Text] [Related]  

  • 13. Colchicine-induced rhabdomyolysis: the whole is greater than the sum of its parts!
    Vasudevan AR; Uthamalingam S; Kumar S; Tamarin F; Brensilver JM
    Am J Med; 2003 Aug; 115(3):249. PubMed ID: 12935834
    [No Abstract]   [Full Text] [Related]  

  • 14. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics.
    Landesman KA; Stozek M; Freeman NJ
    Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rhabdomyolysis, acute renal failure and use of cerivastatin combined with gemfibrozil. New evidence].
    SantaCruz PL; González A; León ME; Fernández MY
    Nefrologia; 2002; 22(3):301-2. PubMed ID: 12123135
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rhabdomyolysis and anuric kidney failure induced by the treatment with a gemfibrozil-cerivastatin combination].
    Sirvent AE; Cabezuelo JB; Enríquez R; Amorós F; González C; Reyes A
    Nefrologia; 2001; 21(5):497-500. PubMed ID: 11795020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy--a case report.
    Ozdemir O; Boran M; Gökçe V; Uzun Y; Koçak B; Korkmaz S
    Angiology; 2000 Aug; 51(8):695-7. PubMed ID: 10959522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Septic-toxic shock due to rhabdomyolysis in a patient treated with fenofibrate].
    Duda-Król W; Jórasz I; Dabrowska M; Polubiec A; Kusz-Rynkun A
    Wiad Lek; 2000; 53(7-8):454-7. PubMed ID: 11070769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhabdomyolysis triggered by cytomegalovirus infection in a heart transplant patient on concomitant cyclosporine and atorvastatin therapy.
    Wong WM; Wai-Hung Shek T; Chan KH; Chau E; Lai KC
    J Gastroenterol Hepatol; 2004 Aug; 19(8):952-3. PubMed ID: 15242511
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatal rhabdomyolysis caused by lipid-lowering therapy.
    Federman DG; Hussain F; Walters AB
    South Med J; 2001 Oct; 94(10):1023-6. PubMed ID: 11702815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.